產品描述: | AF38469 is a new, specific and orally bioavailable Sortilin inhibitor (IC50: 330 nM). |
靶點: |
Neurotensin Receptor;NeurotensinReceptor |
體外研究: |
AF38469 showed no inhibition or stimulation of >50% at 10 μM in a standard selectivity panel of ca. 70 targets run at CEREP. Importantly AF38469 showed no activity against the NTR1 receptor. In addition, AF38469 showed no activity against a selected panel of targets known to bind acidic molecules (d-Opioid, GPR40, PPARd, EP1, Angiotensin AT1, Endothelin ETA & B, MMP-12). AF38469 will serve as an important tool to further delineate the biology of Sortilin, and to facilitate the evaluation of the therapeutic potential of this protein. |
參考文獻: |
1. Schroder TJ, et al. The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin. Bioorg Med Chem Lett. 2014 Jan 1;24(1):177-80. |
溶解性: |
soluble in DMSO |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
3.084 ml |
15.42 ml |
30.84 ml |
5 mM |
0.617 ml |
3.084 ml |
6.168 ml |
10 mM |
0.308 ml |
1.542 ml |
3.084 ml |
50 mM |
0.062 ml |
0.308 ml |
0.617 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |